Organon & Co. (OGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5B 5B 7.5B Q4 '20: 6.5B Q1 '21: 6.3B Q2 '21: 6.3B Q3 '21: 6.3B Q4 '21: 6.3B Q1 '22: 6.4B Q2 '22: 6.4B Q3 '22: 6.3B Q4 '22: 6.2B Q1 '23: 6.1B Q2 '23: 6.2B Q3 '23: 6.2B Q4 '23: 6.3B Q1 '24: 6.3B Q2 '24: 6.3B Q3 '24: 6.4B Q4 '24: 6.4B Q1 '25: 6.3B Q2 '25: 6.3B Q3 '25: 6.3B Q4 '25: 6.2B Q1 '26: 6.2B Q2 '26: 6.1B Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 1.5B 3B 4.5B Q4 '23: 3.7B Q1 '24: 3.7B Q2 '24: 3.7B Q3 '24: 3.7B Q4 '24: 3.7B Q1 '25: 3.6B Q2 '25: 3.5B Q3 '25: 3.5B Q4 '25: 3.3B Q1 '26: 3.3B Q2 '26: 3.2B Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

0 800M 1.6B 2.4B Q4 '20: 2.2B Q1 '21: 1.9B Q2 '21: 1.7B Q3 '21: 1.5B Q4 '21: 1.4B Q1 '22: 1.3B Q2 '22: 1.1B Q3 '22: 1B Q4 '22: 917M Q1 '23: 746M Q2 '23: 754M Q3 '23: 585M Q4 '23: 1B Q1 '24: 1B Q2 '24: 1B Q3 '24: 1.3B Q4 '24: 864M Q1 '25: 750M Q2 '25: 700M Q3 '25: 501M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Cost of Revenue TTM

0 1B 2B 3B Q4 '20: 2.1B Q1 '21: 2.2B Q2 '21: 2.3B Q3 '21: 2.4B Q4 '21: 2.4B Q1 '22: 2.4B Q2 '22: 2.4B Q3 '22: 2.3B Q4 '22: 2.3B Q1 '23: 2.3B Q2 '23: 2.4B Q3 '23: 2.4B Q4 '23: 2.5B Q1 '24: 2.6B Q2 '24: 2.6B Q3 '24: 2.7B Q4 '24: 2.7B Q1 '25: 2.7B Q2 '25: 2.7B Q3 '25: 2.8B Q4 '25: 2.9B Q1 '26: 2.9B Q2 '26: 2.9B Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 1B 2B 3B Q4 '20: 2.3B Q1 '21: 2.8B Q2 '21: 2.5B Q3 '21: 2.6B Q4 '21: 2.2B Q1 '22: 983M Q2 '22: 689M Q3 '22: 638M Q4 '22: 858M Q1 '23: 849M Q2 '23: 725M Q3 '23: 669M Q4 '23: 799M Q1 '24: 761M Q2 '24: 1.1B Q3 '24: 946M Q4 '24: 939M Q1 '25: 938M Q2 '25: 826M Q3 '25: 949M Q4 '25: 700M Q1 '26: 850M Q2 '26: 737M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 900M 1.8B 2.7B Q4 '20: 2B Q1 '21: 2.6B Q2 '21: 2.3B Q3 '21: 2.3B Q4 '21: 2B Q1 '22: 796M Q2 '22: 516M Q3 '22: 446M Q4 '22: 662M Q1 '23: 640M Q2 '23: 490M Q3 '23: 434M Q4 '23: 548M Q1 '24: 510M Q2 '24: 854M Q3 '24: 747M Q4 '24: 764M Q1 '25: 777M Q2 '25: 658M Q3 '25: 777M Q4 '25: 538M Q1 '26: 683M Q2 '26: 567M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q1 '20: 253.5M Q2 '20: 253.5M Q3 '20: 253.5M Q1 '21: 253.5M Q2 '21: 253.8M Q3 '21: 254.2M Q1 '22: 255.1M Q2 '22: 255.2M Q3 '22: 255.1M Q1 '23: 256.2M Q2 '23: 256M Q3 '23: 256.3M Q1 '24: 258.4M Q2 '24: 258.6M Q3 '24: 259.8M Q1 '25: 261M Q2 '25: 260.2M Q3 '25: 260.7M Q1 '26: 262.9M Q2 '26: 270.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q4 '20: 8.53 Q1 '21: 7.33 Q2 '21: 6.87 Q3 '21: 5.98 Q4 '21: 5.32 Q1 '22: 5.10 Q2 '22: 4.34 Q3 '22: 3.96 Q4 '22: 3.59 Q1 '23: 2.92 Q2 '23: 2.95 Q3 '23: 2.29 Q4 '23: 4.00 Q1 '24: 4.09 Q2 '24: 3.89 Q3 '24: 5.04 Q4 '24: 3.32 Q1 '25: 2.87 Q2 '25: 2.68 Q3 '25: 1.91 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.